Inventor · disambiguated record
Peter Sportelli
Also filed as: SPORTELLI PETER
4 granted patents·4 pending applications·11 citations·filing 2013–2022
69Inventor score
Files withTG THERAPEUTICS INC8
Top patents by PatentIndex Score
8 records- 0189US11814439B1Anti-CD20 antibody compositionsTG THERAPEUTICS INC·Filed 2022·Granted Nov 14, 2023·2 cites·19 claims
- 0283US10966977B2Combination of anti-CD20 antibody, P13 kinase-delta selective inhibitor, and BTK inhibitor to treat b-cell proliferative disordersTG THERAPEUTICS INC·Filed 2017·Granted Apr 6, 2021·4 cites·20 claims
- 0378US9694071B2Combination of anti-CD20 antibody and PI3 kinase selective inhibitorTG THERAPEUTICS INC·Filed 2013·Granted Jul 4, 2017·5 cites·25 claims
- 0459US2020323981A1Combination of Anti-CD20 Antibody and PI3 Kinase Selective InhibitorTG THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0557US10729768B2Combination of anti-CD20 antibody and PI3 kinase selective inhibitorTG THERAPEUTICS INC·Filed 2017·Granted Aug 4, 2020·0 cites·35 claims
- 0655US2021169878A1Combination of anti-cd20 antibody, p13 kinase-delta selective inhibitor, and btk inhibitor to treat b-cell proliferative disordersTG THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0750US2022143026A1Triple combination to treat b-cell malignanciesTG THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0840US2019247399A1Combination of an anti-cd20 antibody, pi3 kinase-delta inhibitor, and anti-pd-1 or anti-pd-l1 antibody for treating hematological cancersTG THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →